Article
Comparison of the genomic background of MET-altered carcinomas of the lung: biological differences and analogies
20 Nov 2018
Abstract excerpt
Although non-small-cell lung cancer is a leading cause of cancer-related deaths, the molecular characterization and classification of its genetic alterations has drastically changed treatment options and overall survival within the last few decades. In particular, tyrosine kinase inhibitors targeting specific molecular alterations, among other MET, have greatly improved the prognosis of non-small-cell lung cancer...
Topics
Join the communities discussing this publication.